These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2239078)

  • 1. Pharmacokinetics of the antiprogesterone RU 486: no correlation to clinical performance of RU 486.
    Heikinheimo O; Ylikorkala O; Turpeinen U; Lähteenmäki P
    Acta Endocrinol (Copenh); 1990 Sep; 123(3):298-304. PubMed ID: 2239078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiprogesterone steroid RU486. Pharmacokinetics and receptor binding in humans.
    Heikinheimo O
    Acta Obstet Gynecol Scand; 1990; 69(4):357-8. PubMed ID: 2244471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationships of RU 486.
    Heikinheimo O; Kekkonen R
    Ann Med; 1993 Feb; 25(1):71-6. PubMed ID: 8382070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.
    Avrech OM; Golan A; Weinraub Z; Bukovsky I; Caspi E
    Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of placental protein 12 and chorionic gonadotrophin following RU 38486 and gemeprost for termination of first trimester pregnancy.
    Olajide F; Howell RJ; Wass JA; Holly JM; Bohn H; Grudzinskas JG; Chapman MG; Chard T
    Hum Reprod; 1989 Apr; 4(3):337-40. PubMed ID: 2715311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue and serum levels of steroid hormones and RU 486 after administration of mifepristone.
    Wang JD; Shi WL; Zhang GQ; Bai XM
    Contraception; 1994 Mar; 49(3):245-53. PubMed ID: 8200218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
    Couzinet B; Le Strat N; Ulmann A; Baulieu EE; Schaison G
    N Engl J Med; 1986 Dec; 315(25):1565-70. PubMed ID: 3785321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
    Birgerson L; Odlind V
    Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 369 abortions conducted by mifepristone (RU486) associated with sulprostone in a French family planning center.
    Thonneau P; Fougeyrollas B; Spira A
    Fertil Steril; 1994 Apr; 61(4):627-31. PubMed ID: 7512053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose and time dependent rise of plasma cortisol following administration of mifepristone in early pregnancy.
    Thong KJ; Brooks AN; Baird DT
    Br J Obstet Gynaecol; 1993 Sep; 100(9):880-2. PubMed ID: 8218022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester of pregnancy.
    Hill NC; Selinger M; Ferguson J; MacKenzie IZ
    Hum Reprod; 1991 Mar; 6(3):458-62. PubMed ID: 1955558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the anti-progestin mifepristone (RU 486) on plasma prostaglandin metabolite levels in early pregnancy and its influence on pregnancy termination.
    Hill NC; López Bernal A; Ferguson J; MacKenzie IZ
    Acta Obstet Gynecol Scand; 1990; 69(4):321-5. PubMed ID: 2244464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the antiprogesterone RU 486 in women during multiple dose administration.
    Heikinheimo O
    J Steroid Biochem; 1989 Jan; 32(1A):21-5. PubMed ID: 2913396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of failed attempted abortion with the antiprogestin mifepristone (RU 486).
    Grimes DA; Bernstein L; Lacarra M; Shoupe D; Mishell DR
    Am J Obstet Gynecol; 1990 Apr; 162(4):910-5; discussion 915-7. PubMed ID: 2183618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and metabolism of RU 486.
    Lähteenmäki P; Heikinheimo O; Croxatto H; Spitz I; Shoupe D; Birgerson L; Luukkainen T
    J Steroid Biochem; 1987; 27(4-6):859-63. PubMed ID: 3695508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of abortion in early pregnancy with mifepristone.
    Somell C; Olund A
    Gynecol Obstet Invest; 1990; 29(1):13-5. PubMed ID: 2351330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.